VEGFA, as a growth factor essential for angiogenesis, inhibits the expression of Smad3 and miR192, thereby suppressing IGF-β-induced endothelial interstitial transformation and ameliorating renal fibrosis (55). The gene discussed is SMAD3; the disease is renal fibrosis.